Skip to main content

Tourette's Disorder: A study on Ecopipam tablets in patients with Tourette's Disorder

This study uses the medication Ecopipam to treat Tourette's Disorder. The main purpose is to learn how well Ecopipam (the study drug) works when taken continuously, and how safe Ecopipam is compared to a placebo (an inactive material that looks like the study drug, but doesn't have any active study drug). - Age range: Children (6 and older), adolescents and adults (>18 years old). - Must have a diagnosis of Tourette's Disorder. - Participation in the study lasts approximately 30 weeks (7 months).

Interested in learning more?

Full Study Name: Tourette's Study with Ecopipam